Pfizer Molecular Profile Data for Cell Lines
Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
PROVIDER: GSE34211 | GEO | 2012/01/19
SECONDARY ACCESSION(S): PRJNA149679
REPOSITORIES: GEO
Similar Datasets
Project description:Baseline gene expression for cell lines growing in culture were measured by Affymetrix U133Plus2 arrays. Copy Number Variation for selected cell lines was also measured. Baseline gene expression for cell lines growing in culture were measured by Affymetrix U133Plus2 arrays. Three different sources of arrays were combined. Arrays were from Pfizer, Wyeth Breast Panel, and Wyeth NCI50 subset of NCI60 cell lines. CNV was determined by Affymetrix SNP6.0 arrays.
2012-01-19 | E-GEOD-34211 | biostudies-arrayexpress
Project description:Gene expression and copy number variation arrays for parental GTL16 and GTL16 clones resistant to c-Met inhibitor. Affymetrix U133 Plus 2.0 and SNP 6.0 chips were used to assess gene expression and copy number variation, respectively, of GTL16 and resistant GTL16 clones.
2012-06-21 | E-GEOD-27692 | biostudies-arrayexpress
Project description:We measured the baseline expression levels of genes in members of the CEPH pedigrees using Affymetrix Human Genome Focus Arrays. Arrays were analyzed using MAS 5.0 software (Affymetrix). Keywords = natural variation Keywords = human Keywords: other
2004-08-12 | GSE1485 | GEO
Project description:Gene expression and copy number variation arrays for parental GTL16 and GTL16 clones resistant to c-Met inhibitor.
2012-06-22 | GSE27692 | GEO
Project description:We measured baseline gene expression profiles for a panel of 51 breast cancer cell lines using the Affymetrix U133A array.
2006-11-21 | E-TABM-157 | biostudies-arrayexpress
Project description:Lymphoblastoid cell lines (LCLs), originally collected as renewable sources of DNA, are now being used as a model system to study genotype-phenotype relationships in human cells. These cell lines have been used to search for genetic variants that are associated with drug response as well as with more basic cellular traits such as RNA levels. In setting out to extend such studies by searching for genetic variants contributing to drug response, we observed that phenotypes in LCLs were, in our lab and others, significantly affected by experimental confounders (i.e. in vitro growth rate, metabolic state, and relative levels of the Epstein-Barr virus used to transform the cells). As we did not find any SNPs associated with genome-wide significance to drug response, we evaluated whether incorporating RNA expression levels (and eQTLs) in the analysis could increase power to detect such effects. As previously shown, cis-acting eQTLs were detectable for a sizeable fraction of RNAs and baseline levels of many RNAs predicted response to several drugs. However, we found only limited evidence that SNPs influenced drug response through their effect on expression of RNA. Efforts to use LCLs to map genes underlying cellular traits will require great care to control experimental confounders, unbiased methods for integrating and interpreting such multi-dimensional data, and much larger sample sizes than have been applied to date. Experiment Overall Design: We studied 269 cell lines densely genotyped by the International HapMap Project [31]. Cell lines were cultured and characterized at baseline for a variety of cellular phenotypes including growth rate, ATP levels, mitochondrial DNA copy number, EBV copy number, and measures of B-cell relevant cell surface receptors and cytokine levels. Each cell line was exposed in 384-well plates to a range of doses for each of seven drugs selected based on their divergent mechanisms of action and importance in clinical use for treatment of B-cell diseases, focusing on anti-cancer agents: 5-fluorouracil (5FU), methotrexate (MTX), simvastatin, SAHA, 6-mercaptopurine (6MP), rapamycin, and bortezomib. Drug response was measured using Celltiter Glo, an ATP-activated intracellular luminescent marker that, when compared to mock-treated control wells, can represent relative levels of cellular viability and metabolic activity. RNA was collected at baseline and RNA transcript levels were measured genome-wide on the Affymetrix platform. Baseline characterization and plating for drug response experiments was performed using batches of 90 cell lines from each HapMap analysis panel (CEU, JPT / CHB, and YRI) on each of three experiment days. The order of cell lines within each panel was randomized to avoid inducing artificial intra-familial correlation. Each drug was tested at a range of doses around the expected IC50 as reported for the drug by the NCI DTP; each dose of drug was tested in two wells per plate and on two separate plates. These replicate measurements for each cell line allowed assessment of intra-experimental variation. To evaluate day-to-day (i.e. inter-experimental) variation in all traits, a subset of 90 cell lines (30 from each of the three HapMap panels) was grown from a fresh aliquot and the entire experiment was repeated. To evaluate the effect of technical error on measured RNA levels, a set of 22 RNAs previously expression profiled (using Illumina HumanChip) at Wellcome Trust Sanger Institute (WTSI) (generously provided by Emmanouil T. Dermatsakis) was included in expression profiling at the Broad on Affymetrix arrays. Data can be downloaded from the Broad Institute web site: (http://www.broad.mit.edu/~yelensky/cell_lines_paper/). Please see Materials and Methods for details of QC, normalization, etc.
2008-06-19 | E-GEOD-11582 | biostudies-arrayexpress
Project description:We evaluated 6 established ostesarcoma cell lines. Copy Number Variation and loss-of-heterozygosity status were explored to look for similar patterns across cell lines
2023-11-22 | GSE240546 | GEO
Project description:Genome variation profiling of BRAFi resistant melanoma cell lines comapered to the original ones by Affymetrix CytoScan 750K microarray
2019-01-31 | GSE114488 | GEO
Project description:Many preclinical therapy studies have focused on a small number of well-described mouse allograft or human xenograft models that poorly represent the heterogeneity of human disease. Here we have assembled a panel of mouse mammary cell lines derived from spontaneously-arising mouse mammary tumors or from mammary tumors arising in genetically engineered mouse models. We used the Affymetrix Mouse Diversity Genotyping Array to address DNA copy number variation in the genomes of the cell lines of this panel. The resulting information about regions of amplification and deletion should help inform biological analyses as well as provide a reference for cell line authentication/identification.
2016-06-15 | GSE69902 | GEO
Project description:The genomic loci with copy number alterations are known to harbor cancer genes. We investigated a comprehensive panel of gastric cancer cell lines for their genome-wide copy number alterations. Eighteen gastric cancer cell lines were profiled using Affymetrix 500K SNP arrays. For copy number calculation, seven independent normal blood samples were profiled together. The copy numbers were calculated genome-wide, in these cell lines with high resolution and reveal the cell line specific amplification and copy number changes.
2015-08-04 | GSE51074 | GEO